Ovarian Steroid Cell Tumor — Trials

Ovarian Steroid Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06328491	Erdafitinib in Metastatic Steroid-cell Ovarian Cancer	completed	N/A	1	University Health Network, TorontoOTHER	1	Mar 25, 2024	clinicaltrials
NCT01042522	Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors	unknown	Phase 2	63	GOG FoundationNETWORK	1	Jan 25, 2022	clinicaltrials
NCT00006227	Paclitaxel in Treating Patients With Ovarian Stromal Cancer	completed	Phase 2	31	Gynecologic Oncology GroupNETWORK	2	Mar 5, 2020	clinicaltrials
NCT00748657	Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary	completed	Phase 2	36	National Cancer Institute (NCI)NIH

Data updated 22 days agoSource updated Mar 25, 2024source: clinicaltrials